OmniAb (OABI) Asset Utilization Ratio (2022 - 2026)

OmniAb (OABI) reported Asset Utilization Ratio of 0.1 for Q1 2026, up 14.97% year-over-year from 0.08 in Q1 2025, and up 59.22% quarter-over-quarter from 0.06 in Q4 2025.

OmniAb (OABI) Asset Utilization Ratio (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Asset Utilization Ratio data on file, last reported at 0.1 in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.1, up 14.97% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.1 (up 14.97% YoY), and the FY2025 annual result was 0.06, down 20.88% from the prior year.
  • Asset Utilization Ratio advanced to 0.1 in Q1 2026 per OABI's latest filing, from 0.06 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.18 in Q4 2022 and troughed at 0.06 in Q1 2024.
  • A 5-year average of 0.1 and a median of 0.08 in 2024 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio sank 63.65% in 2024, then soared 46.39% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.18 in 2022, then tumbled by 50.3% to 0.09 in 2023, then declined by 9.84% to 0.08 in 2024, then dropped by 23.88% to 0.06 in 2025, then jumped by 59.22% to 0.1 in 2026.
  • Business Quant data shows OABI's Asset Utilization Ratio at 0.1 in Q1 2026, 0.06 in Q4 2025, and 0.07 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 0.10

Historic Data

Download Data
DateValue
Mar 31, 2026 0.10
Dec 31, 2025 0.06
Sep 30, 2025 0.07
Jun 30, 2025 0.08
Mar 31, 2025 0.08
Dec 31, 2024 0.08
Sep 30, 2024 0.06
Jun 30, 2024 0.06
Mar 31, 2024 0.06
Dec 31, 2023 0.09
Sep 30, 2023 0.16
Jun 30, 2023 0.16
Mar 31, 2023 0.16
Dec 31, 2022 0.18